About: First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report
Creator	Bemtgen, Xavier
Source	Medline; PMC; WHO
abstract	The novel coronavirus severe acute respiratory syndrome coronavirus 2 is infecting hundreds of thousands of humans around the globe. The coronavirus disease 2019 (COVID-19) is known to generate mild as well as critical courses. Complications on the intensive care units include acute respiratory distress syndrome, acute cardiac, and kidney injury as well as shock. Here, we present the first case report of a successful treatment of a COVID-19 patient presenting with adult respiratory distress syndrome plus refractory combined cardiogenic and vasoplegic shock, which could be successfully stabilized after implantation of a percutaneous ventricular assist device plus an extracorporeal membrane oxygenation. Although such intense treatment might not be feasible in case of a health care disaster as described for the hot spots of the COVID-19 pandemic, it might encourage treatment of younger patients on intensive care units not overcrowded by critically ill patients.
has issue date	2020-05-11(xsd:dateTime)
bibo:doi	10.1097/mat.0000000000001178
bibo:pmid	32304394
has license	no-cc
sha1sum (hex)	7e262978aedfd5757b34f838c17d3a466823bf8f
schema:url	https://doi.org/10.1097/mat.0000000000001178
resource representing a document's title	First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report
has PubMed Central identifier	PMC7217127
has PubMed identifier	32304394
schema:publication	ASAIO J
resource representing a document's body	covid:7e262978aedfd5757b34f838c17d3a466823bf8f#body_text
is schema:about of	named entity 'hundreds' named entity 'COVID-19' named entity 'humans' named entity 'pandemic' named entity 'acute' named entity 'generate' named entity 'Here' named entity 'patient' named entity 'The' named entity 'intensive care units' named entity 'injury' named entity 'coronavirus' named entity 'cardiogenic' named entity 'percutaneous' named entity 'health care' named entity 'intensive care units' named entity 'intensive care units' named entity 'case report' named entity 'kidney injury' named entity 'COVID-19 pandemic' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'percutaneous' named entity 'April 2020' named entity 'Aachen' named entity 'ICU' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity 'COVID-19' named entity 'fever' named entity 'acute kidney failure' named entity 'lopinavir' named entity 'hemodynamic support' named entity 'blood flow' named entity 'ARDS' named entity 'Impella' named entity 'prognosis' named entity 'norepinephrine' named entity 'acute respiratory distress syndrome' named entity 'infection' named entity 'hemodynamic' named entity 'world health organization' named entity 'Impella' named entity 'Berlin' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'Extracorporeal Life Support Organization' named entity 'ritonavir' named entity 'emergency department' named entity 'diuretic' named entity 'WHO' named entity 'cardiogenic shock' named entity '100% oxygen' named entity 'clinical presentation' named entity 'critically ill patients' named entity 'hemodynamic' named entity 'Left ventricular' named entity 'COVID' named entity 'dyspnea' named entity 'polymerase chain reaction' named entity 'acute myocardial infarction' named entity 'ventricular assist device' named entity 'cardiac output' named entity 'oxygen' named entity 'COVID' named entity 'COVID' named entity 'COVID-19 pandemic' named entity 'prognosis' named entity 'ICU' named entity 'extracorporeal' named entity 'cardiology' named entity 'heart failure' named entity 'blood flow' named entity 'empiric antibiotic' named entity 'class II' named entity 'hemodynamic monitoring' named entity 'dyspnea' named entity 'ICUs' named entity 'ICU' named entity 'prognosis' named entity 'end-diastolic' named entity 'severe acute respiratory syndrome coronavirus 2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software